Rothschild Investment LLC’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.1K Buy
245
+173
+240% +$20.9K ﹤0.01% 1457
2026
Q1
$11.8K Buy
72
+36
+100% +$5.54K ﹤0.01% 1620
2025
Q4
$6.26K Buy
36
+32
+800% +$5.84K ﹤0.01% 1768
2025
Q3
$576 Buy
+4
New +$490 ﹤0.01% 2785
2025
Q2
– Sell
-240
Closed -$18.3K – 3107
2025
Q1
$18.3K Buy
240
+85
+55% +$6.5K ﹤0.01% 1023
2024
Q4
$10.7K Buy
155
+10
+7% +$720 ﹤0.01% 1135
2024
Q3
$10.6K Buy
145
+105
+263% +$7.75K ﹤0.01% 1132
2024
Q2
$2.68K Buy
40
+25
+167% +$970 ﹤0.01% 1312
2024
Q1
$407 Buy
+15
New +$420 ﹤0.01% 1437

Other funds holding INSM

Rothschild Investment LLC's INSM Position: Q2 2026 in Review

Rothschild Investment LLC increased its Insmed (INSM) stake by 240% in Q2 2026, buying an estimated $20.9K and bringing the position to 245 shares worth $26.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1457.

Rothschild Investment LLC first reported a position in INSM in Q1 2024 and has held it in 9 quarters since. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Rothschild Investment LLC held 245 shares of Insmed worth $26.1K as of Q2 2026.
  • Rothschild Investment LLC bought 173 Insmed shares in Q2 2026, an estimated $20.9K.
  • Insmed made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1457 holding.
  • Rothschild Investment LLC first reported a position in Insmed in Q1 2024 and has held it in 9 quarters since.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.